The core theme is the intricate molecular regulation of osteoclast activity, primarily through the RANK Ligand/RANK signaling pathway and its counter-regulatory mechanism involving osteoprotegerin (OPG), highlighting how hormonal influences modulate this balance to affect bone resorption and preservation.
Mind Map
คลิกเพื่อขยาย
คลิกเพื่อสำรวจ Mind Map แบบอินเตอร์แอคทีฟฉบับเต็ม
Osteoclasts and their precursor cells are regulated
by different signaling pathways and molecules.
One key regulatory molecule is the protein RANK Ligand,
which is produced by a variety of cell types,
including osteoblasts and their precursor cells.
This protein has been shown to exert its effects on osteoclasts
and their precursors through an interaction
with the cell surface receptor RANK.
The interaction between RANK Ligand and its receptor rank
triggers the activation of signaling pathways,
which are involved in the differentiation,
activation, and survival of osteoclasts.
Such signaling pathways
can trigger the fusion of precursor cells
to form mature multi-nucleated osteoclasts.
On these mature cells,
RANK Ligand can interact with its receptor,
promoting osteoclast activity and survival,
leading to increased resorption of bone.
To balance the effect of RANK Ligand,
osteoprotegerin or OPG is secreted from osteoblasts.
This protein acts like a decoy in binding to RANK Ligand,
preventing RANK Ligand from interacting with
and activating its receptor on the surface of osteoclasts.
Various hormones and cytokines modulate the balance
between RANK Ligand and OPG. For example, parathyroid hormone
stimulates the production of RANK Ligand,
while at the same time
repressing the expression of OPG,
an effect thought to increase the activity of osteoclasts.
Conversely, estrogen can increase the expression of OPG
and inhibits RANK Ligand signaling.
These changes, which are thought to reduce the activity
in osteoclasts may contribute to estrogen’s ability
